Indivior Pharmaceuticals (INDV) Change in Inventory (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Change in Inventory of $1.0 million for Q1 2026, up 120.0% year-over-year from $454545.5 in Q1 2025, and up 150.0% quarter-over-quarter from -$2.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Change in Inventory (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 120.0% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at -$12.0 million (down 209.09% YoY), while the FY2025 annual figure was -$18.0 million, down 141.86% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.0 million, up from -$2.0 million in the prior quarter.
- The five-year high for Change in Inventory was $27.0 million in Q1 2024, with the low at -$17.0 million in Q2 2025.
- The 3-year median for Change in Inventory is $2.0 million (2024), against an average of $2.9 million.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory plunged 312.5% in 2025, then surged 120.0% in 2026.
- Indivior Pharmaceuticals' Change in Inventory stood at $2.0 million in 2024, then slumped by 200.0% to -$2.0 million in 2025, then soared by 150.0% to $1.0 million in 2026.
- Business Quant data shows INDV's Change in Inventory at $1.0 million in Q1 2026, -$2.0 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.00 Mn |
| Jun 30, 2026 | -4.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | -17.00 Mn |
| Jun 30, 2025 | -17.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Mar 31, 2024 | 27.00 Mn |
| Mar 31, 2024 | 27.00 Mn |